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Recent achievements in the genetic correction of
keratinocytes isolated from patients with junctional
epidermolysis bullosa have paved the way to a gene
therapy approach for the disease. Because gene
therapy protocols require preclinical validation in
animals, we have characterized spontaneous animal
models of junctional epidermolysis bullosa. In this
study we have elucidated the genetic basis of the
hereditary junctional mechanobullous disease in the
Belgian horse, a condition characterized by blistering
of the skin and mouth epithelia, and exungulation
(loss of the hoof). Immuno¯uorescence analysis asso-
ciated the condition to the absent expression of the
g2 chain of laminin 5 and designated Lamc2 as the
candidate gene. Comparative analysis of the nucleo-
tide sequence of the full-length g2 cDNA isolated by
reverse transcription polymerase chain reaction amp-
li®cation of total RNA puri®ed from the epithelium
of a junctional epidermolysis bullosa foal and a
healthy control disclosed a homozygous basepair
insertion (1368insC) in the affected animal. Mutation
1368insC results in a downstream premature termin-
ation codon and is predicted to cause absent expres-
sion of the laminin g2 polypeptide. Our results also
show that: (i) the horse junctional epidermolysis bul-
losa genetically corresponds to the severe Herlitz
form of junctional epidermolysis bullosa in man; (ii)
the amino acid sequence and structure of the horse
laminin g2 chain are virtually identical to the human
counterpart; (iii) the moderate eruption of skin blis-
ters in the affected animals with respect to the
human Herlitz junctional epidermolysis bullosa
patients correlates with the protection provided by
hair. Our observations suggest that the affected foals
are a convenient source of epithelial cells from tis-
sues that cannot be obtained from human junctional
epidermolysis bullosa patients, and imply that hair-
less strains of animals with recessive skin disorders
would be the best models for in vivo gene therapy
approaches to skin blistering diseases. Key words:
epitheliogenesis imperfecta/genodermatosis/Lamc2. J Invest
Dermatol 119:684±691, 2002
I
In recent years, novel approaches have been explored to treat
inherited skin disorders in which a failing function of the
keratinocytes cannot be compensated by conventional
pharmacologic treatments (Meneguzzi and Vailly, 2000).
Autologous transplantation of epithelial sheets derived from
ex vivo genetically modi®ed keratinocytes is the most direct
approach that may allow replacement of the defective tissue and
restoration of a de®cient function (Spirito et al, 2001). Transduction
by retroviral vectors expressing a therapeutic gene has been shown
to correct the genetic defects in keratinocytes isolated from patients
affected by X-linked ichthyosis, lamellar ichthyosis, and junctional
epidermolysis bullosa (JEB), both in vitro and in vivo (Choate et al,
1996; Freiberg et al, 1997; Dellambra et al, 1998; Vailly et al, 1998;
Seitz et al, 1999). The expression of the curative transgenes
is permanent in epithelia reconstructed using keratinocytes
genetically modi®ed ex vivo and transplanted onto immune-
de®cient mice. These achievements demonstrate that successful
targeting of epithelial stem-like cells by retroviral vectors allows
generation of an engineered self-renovating integument. The fate
of the transgene product expressed by the engineered epithelia
grafted onto immunocompetent hosts, however, remains an open
question (Ghazizadeh et al, 1999).
JEB is a recessive inherited disease that causes blister formation
after minor trauma (Fine et al, 2000). The plane of the blisters
localizes within the lamina lucida of the dermal±epidermal
junction. The heterogeneity of the clinical phenotypes correlates
with a variety of genetic mutations in the genes encoding three
components of the hemidesmosome-anchoring ®lament complex
(Uitto and Pulkkinen, 2001). The mild JEB variants that do not
affect the patients' life span are associated with mutations in integrin
a6b4, laminin 5, and collagen XVII, whereas the severe and life
threatening variants of the conditions are associated with absent
expression of integrin a6b4 and laminin 5 (Uitto and Pulkkinen,
2001). Genetic correction of primary JEB keratinocytes enriched in
stem cells has been reported to fully restore cell adhesion and stably
maintain the high proliferative and clonogenic potential of the
engineered cells that upon grafting onto immune-de®cient mice
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regenerate ®rmly adhering epithelia (Dellambra et al, 1998;
Robbins et al, 2001). Evaluation of therapeutic ef®cacy of the
gene therapy approach in preclinical trials, however, is so far
hampered by the unavailability of suitable immunocompetent JEB
animal models. Indeed, in mice strains with null mutations in the
genes for laminin 5, the homozygous JEB pups die shortly after
birth (Kuster et al, 1997; Ryan et al, 1999).2 The development of
conditional mouse models that harbor mutations found in JEB
patients is expected to provide the means to assess gene therapy
approaches. Comparative genotype±phenotype correlations, how-
ever, may be biased by morphologic dissimilarities between human
and adult mouse skin, such as, for instance, the reduced number of
cell layers in the mouse epidermis and the presence of dense hair
that protects the integument of animals from trauma.
To establish a genotype±phenotype correlation in a spontaneous
animal model of JEB, we have assessed the molecular basis of a
mechanobullous disease with a suspected inherited etiology (online
Mendelian inheritance in animals, OMIA #000342) that has been
described in Belgian foals in the U.S.A. (Kohn et al, 1989) and
Canada (Shapiro and McEwen, 1995). This condition is also
designated ``epitheliogenesis imperfecta neonatorum'' (OMIA
#000348) (Berthelsen and Eriksson, 1935). Clinically, the affected
foals exhibit generalized skin blistering at the pressure points, severe
oral cavity involvement, and exungulation (Frame et al, 1988; Kohn
et al, 1989; Shapiro and McEwen, 1995). Electron microscopy
examination revealed junctional blistering and abnormal hemi-
desmosomes (Johnson et al, 1988); therefore, by analogy to the
ultrastructural features of human JEB, the condition was also
designated ``hereditary junctional mechanobullous disease''
(Gourreau et al, 1990). In this study we report the immunochemical
characterization of this disorder, and provide the genetic evidence
that, despite the reduced tendency of the skin to form blisters, the
condition corresponds to the severe (Herlitz) form of JEB in man.
MATERIALS AND METHODS
Clinical characteristics of the disease in the horse The animals were
Belgian foals, born on different farms in Ontario, Canada, and suffering
from extensive skin blistering associated with severe oral cavity
involvement. Foal no. 1 was the fourth foal of a mare that had
previously had an affected offspring. One day after birth, multiple
ulcerations of the skin were present over the pressure points on the legs
and head. Erosions were also observed on the tongue and the mucous
membrane of rostral maxillae. Foal no. 2 presented multiple mucosal and
epithelial erosions at birth. Multifocal, irregular areas of erosions were
noted over the pressure points of the legs, along the coronary band of all
four hooves, and on the oral and conjunctival mucous membranes. An
abnormally roughened enamel was present over the teeth and there was
evidence of bleeding from oral erosions. In foal no. 3, multiple skin
defects were noticed shortly after birth. Eight days after birth, large,
extensive, and con¯uent ulcerated areas were present over the pressure
points of the body (Fig 1a). The right front hoof had detached and the
underlying lamina was exposed (Fig 1b). The buccal mucous membranes
were hyperemic. Due to the grave prognosis the foal was euthanized and
submitted for necropsy. Foal no. 4 presented ulcerated skin lesions over
the limbs and at the base of the hooves 1 d after birth. Extensive
ulcerations were noted over the gingival mucosa and the soft palate.
Teeth were visible and dysplastic, with white serrated edges (Fig 1c, d).
Biological samples Biopsies were obtained from involved and
noninvolved areas of the skin and from tongue epithelia of the affected
foals. Tissue samples were also obtained from a wild-type unrelated
horse. The biopsies were snap frozen in liquid nitrogen and preserved at
±70°C until processing. Total RNA was puri®ed from the frozen skin
biopsies using the RNable extraction kit (Eurobio, Les Ullis, France).
Genomic DNA was puri®ed from peripheral blood following standard
methods (Sambrook et al, 1989).
Immunohistochemistry Indirect immuno¯uorescence analysis was
performed on 5 mm sections of the frozen tongue samples using
antibodies raised against the human basement membrane components
and crossreacting with the horse counterparts. Polyclonal antibody (pAb)
SE85 is speci®c to the laminin a3 chain (Vidal et al, 1995); pAb SE144
(Vailly et al, 1994) and pAb SE1097 (Gagnoux-Palacios et al, 2001) are
directed against the laminin g2 chain, and monoclonal antibody (mAb)
K140 against the laminin b3 chain (Marinkovich et al, 1992). pAb
GOH3 is speci®c to integrin a6 (Sonnenberg et al, 1987); mAb 233 is
directed against BP180 (Nishizawa et al, 1993), and mAb LH7:2 is
speci®c to the collagen VII C-terminal domain (Sigma
Immunochemical). pAb antilaminin 1 (L9393, Sigma) was also used.
Secondary antibodies were ¯uorescein-isothiocyanate-conjugated goat
antimouse and antirabbit Ig (Dako, Trappes, France), and goat antirat
IgG (Cappel, ICN Biomedicals, Orsay, France). The samples were
processed as previously reported (Gache et al, 1996). The tissue sections
were examined using a Zeiss Axiophot microscope.
Isolation of the horse laminin g2 cDNA Total RNA was puri®ed
from frozen tongue biopsies obtained from a wild-type nonrelated horse.
Five micrograms of RNA were reverse transcribed in a volume of 25 ml
in the presence of 100 U of M-MLV reverse transcriptase (Gibco-BRL,
Life Technologies,). One microliter of the reaction mixture was then
used in polymerase chain reaction (PCR) ampli®cations to obtain
overlapping cDNA fragments spanning the open reading frame of the
horse laminin g2 chain. Speci®cally, eight primer pairs were devised on
the basis of the most conserved nucleotide sequence between the human
(GenBank accession no. Z15008) (Kallunki et al, 1992) and mouse
(GenBank no. NM_008485) (Sugiyama et al, 1995) laminin g2 cDNAs
(not shown). Direct sequencing of the different PCR ampli®cation
Figure 1. Clinical feature of JEB in Belgian horses. A few days
after birth (8 d for the depicted animal) Belgian foals with JEB show
extensive erosions over the pressure points of the carpal, tarsal, and
femor-tibial joints (a) and exungulation of the hoofs (b). Extensive loss of
buccal mucous membrane around the junction of the teeth and gums is
detected at birth, as shown in the case of a 24-h-old Belgian newborn (c,
e). Erosions are associated with eruption of deciduous incisor teeth (c)
and premolar teeth (e), which are irregularly shaped, with serrated edges
and pitted enamel. The oral cavity of a wild-type 8-d-old foal shows no
eruption of the deciduous incisor teeth (d) and displays normal premolar
teeth and buccal mucosa ( f ).
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products resulted in the disclosure of 82% of the horse laminin g2 cDNA
sequence. Primers speci®c to the horse g2 cDNA sequence were then
designed to complete and verify the sequence of the full-length g2
cDNA (Table I). The PCR conditions were as follows: 95°C for 5 min,
followed by 35 cycles at 95°C for 40 s, annealing temperature (Table I)
for 40 s, 72°C for 40 s, and a ®nal elongation for 7 min at 72°C. The
ampli®cation products were puri®ed using a QIAquick kit (Qiagen,
Madison, WI), and were subjected to automated nucleotide sequencing
using an ABI Prism Model 310 Genetic Analyzer (Perkin-Elmer, Foster
City, CA).
To obtain the 5¢ end of the g2 cDNA, the sense oligonucleotide
PCR-5¢L corresponding to a 5¢ noncoding sequence of the human
laminin g2 cDNA (Salo et al, 1999) and the antisense primer PCR-5¢R
speci®c to the horse g2 cDNA sequence were used to amplify a 460 bp
cDNA fragment (Table I). To obtain the 3¢ end of the g2 cDNA, the
antisense primer RT-PCR-3¢ that contains a poly T tag sequence was
used for reverse transcription PCR (RT-PCR) ampli®cation of total
RNA. A PCR was then performed using primers PCR-3¢L (position
3226 on the horse g2 cDNA) and PCR-3¢R (Table I) to obtain the 474
bp 3¢-terminal g2 cDNA fragment. The 474 bp cDNA fragment was
then used as a template for PCR ampli®cation using the nested primers
PCR-3A¢L and PCR-3¢R. The PCR cycling conditions, puri®cation,
and sequence analysis for the isolation of the 5¢ and 3¢ ends were as
previously mentioned. Analysis, alignment, and translation of the
nucleotide sequence into the amino acid sequence were performed using
the software Lalign and Clustal W (Thompson et al, 1994).
Identi®cation of the genetic mutation 1368insC Total mRNA
extracted from skin biopsies of foal no. 1 was reverse transcribed using a
universal oligo-dT and PCR ampli®ed using the nested primer 9R
(Table I). Overlapping cDNA fragments spanning the full-length
sequence of the g2 cDNA were then obtained by PCR ampli®cation
using the primer pairs listed in Table I. The PCR ampli®cation
products were puri®ed and subjected to automated nucleotide
sequencing. The g2 cDNA sequence of the affected foal was compared
with the wild-type nucleotide sequence using the software program
Sequencher (Gene Codes, Ann Arbor, MI).
Identi®cation of mutation 1368insC at the genomic level was per-
formed by PCR ampli®cation of a 170 bp DNA fragment (nucleotides
1291±1461 of g2 cDNA sequence) using genomic DNA as a template
and the following primers: (sense) 5¢-TGTTACTCAGGGGATGAGAA-
3¢ and (antisense) 5¢-CTGGGGGCAGTTATTGCAC-3¢. PCR cycling
conditions were as follows: 5 min at 95°C, followed by 30 s at 95°C, 30
s at 56°C, 30 s at 72°C (35 cycles), and extension for 7 min at 72°C.
After puri®cation the ampli®cation product was submitted to automated
nucleotide sequencing.
RESULTS
Identi®cation of the gene candidate in JEB in the Belgian
horse We have studied four Belgian foals born on three different
farms in Ontario, Canada, and affected by a skin blistering disease.
Immediately after birth, the foals developed generalized cutaneous
blisters and erosions at sites of the body exposed to friction
(Fig 1a). Involvement of the ungueal lamina resulted in hoof loss
(Fig 1b). The oral mucosa exhibited erosions (Fig 1c); the teeth
were apparent and abnormally shaped, with pitted enamel and
serrated edges (Fig 1e). The clinical observations were consistent
with the hallmarks of epidermolysis bullosa. Histological
examination of frozen samples of the blistered skin and mucosa
localized the plane of the cleavage within the basement membrane
zone of the dermal±epidermal junction (not shown). Immuno-
¯uorescence examination of noninvolved epithelia was performed
using antibodies directed against the components of the basement
membrane of the dermal±epidermal junction. Reactivity to pAb
SE144 speci®c to the human laminin g2 chain was absent in the
affected foals (Fig 2a), whereas pAb SE85 and mAb K140 directed
against the human laminin a3 and b3 chains, respectively, were
faintly reactive (Fig 2c, e). Reactivity to collagen type VII
(Fig 2g, h), integrin a6, collagen type XVII, and laminin 1 was
comparable to that observed in wild-type foals (not shown). These
observations suggested that expression of laminin 5 was hampered
in the affected animals and indicated that Lamc2, the gene encoding
the laminin g2 chain, was involved in the etiology of the condition.
We therefore isolated and analyzed the full-length laminin g2
cDNA to identify possible genetic mutation in the gene Lamc2.
Table I. Oligonucleotide primers used to amplify the horse laminin g2 cDNA
Primersa Positionb Nucleotide sequence annealing Temp. (C°) Product size (bp)
1L 1 ATGCCTGCGCTCTGGCTCAG 63 591
1R 592 TGTGGCAGCTGGCGGAATGC
2L 406 GACTCCAAGTGTGACTGTGA 60 388
2R 794 TAGCTCACCTGTTGATTCCC
3L 742 CCTGTCTATTTTGTAGCTCC 57 670
3R 1412 CAGCTGAACCCATTGCGACA
4L 1003 GAGTATCGGAGGTTACTGCG 59 756
4R 1759 GACACTCCACAGGCTCCGAG
5L 1477 CGCTGTGAGCTCTGTGCTGA 65 422
5R 1899 CTCCAGGATCTGGAGCTGCT
6L 1705 GACAAGTGTCGAGCTTGCAA 60 395
6R 2100 TCATCATGAGGTCATCCAGG
7L 1992 GAGAGAAGCCCAGATTTCAC 59 524
7R 2516 GCTTCCATGTCGGTTTGCGT
8L 2312 CAGCCAGTAACATGGAGCAA 60 435
8R 2747 GTCTGTCTCCCATTCTTTCC
9L 2658 GGATGAGTTCAAGCACGTGC 57 514
9R 3172 ACAGCTCTCCTTCCACTTCT
10L 2955 CAAGACGAAGCAAGCAGAAG 60 445
10R 3400 GGCTGTTGATCTGAGTCTTG
PCR-5¢L ±197 GTGAGTCACACCCTGAAACA 57 460
PCR-5¢R 263 GAGTTACAATTGCAGGGTAAAC
RT-PCR 3¢ ± GGCCATGCGTAGACTCTTAA(T)16
PCR-3¢L 3226 GCAGAGGCCCAAAGAGTTG 57 474
Pcr-3¢R ± GGCCATGCGTAGACTCTTAA
PCR-3A¢L 3325 CCTGGCAGTGTGGATGAAGA 57 375
aL, sense primer; R, antisense primer.
bThe position number designates the 5
¢end of each primer in accordance with the horse laminin g2 cDNA sequence (GenBank accession no. AY082802).
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Isolation and characterization of the horse laminin g2
complementary DNA Total RNA extracted from the tongue
epithelia of an unrelated wild-type horse was used for RT-PCR
ampli®cation. The coding sequence of the g2 mRNA was reverse
transcribed and PCR-ampli®ed using sets of oligonucleotide
primers designed on the basis of the sequence homology between
the human (GenBank accession no. Z15008) (Kallunki et al, 1992)
and mouse (GenBank accession no. NM_008485) (Sugiyama et al,
1995) g2 cDNA, and was expected to yield overlapping cDNA
fragments spanning the entire open reading frame of the horse g2
mRNA. Direct sequencing of the PCR ampli®cation products led
to the partial identi®cation (82%) of the horse g2 cDNA sequence.
On the basis of the disclosed cDNA sequence, new sets of
oligonucleotide primers speci®c to the horse g2 cDNA were
designed and used to obtain the full-length nucleotide sequence of
the g2 cDNA (Table I).
The horse g2 cDNA (GenBank accession no. AY082802)
comprises a 3570 bp full-length open reading frame, and a 199 bp
5¢ and a 222 bp 3¢ untranslated region. The polypeptide contains an
N-terminal short arm, rich in EGF-like repeats, and extends into a
long rod-like C-terminal arm. The N-terminal short arm domain V
(residues 28±195) consists of three and a half cysteine-rich EGF-like
Figure 2. Altered expression of laminin g2 in horse JEB. Immuno¯uorescence analysis of frozen sections of tongue epithelia samples
obtained from an affected foal (a, c, e, g) and a healthy unrelated control (b, d, f, h) using antibody SE144 (a, b) speci®c to human laminin g2,
SE85 (c, d) to the human laminin a3 chains, and mAb K140 (e, f) to the human laminin b3 chain. In the JEB foal, immunoreactivity of the
laminin g2 chain is absent, whereas immunoreactivity to the laminin a3 and b3 shows a strong attenuation of the ¯uorescent signal in the
affected animal compared to healthy control. Staining with monoclonal antibody LH7:2 to collagen type VII (g, h) was comparable in both
samples. Scale bar: 50 mm.
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repeats; domain IV (residues 196±382) has a globular structure and
contains two cysteines; domain III (residues 383±607) comprises
four and a half EGF-like repeats and contains the proteolytic
cleavage site YSGD (Gagnoux-Palacios et al, 2001). Domain I/II
(residues 608±1190) constitutes the rod-like long arm of the
polypeptide and is formed by heptad repeats typical of the a-helical
coiled-coil domains of the laminin chains.
Computer-assisted analysis of the nucleotide sequence revealed
that identity of the coding sequence in man and horse (88.6%) is
higher than that between horse and mouse (83.7%) and that
between man and mouse (84.4%). The 5¢ untranslated region
contains a GATAA box, which is located ±113 to ±117 bp from the
initiation ATG, and two AP-1 binding sites at positions ±130 to ±
136 and ±172 to ±178, respectively. Comparison of the 5¢
untranslated region of the horse and the human g2 mRNA
revealed 90.7% identity with two base additions and seven base
deletions.
The horse g2 cDNA encodes a polypeptide of 1190 residues,
which is three amino acids shorter than in man (1193 aa) and two
amino acids shorter than in the mouse (1192 aa) counterpart. As in
man and mouse, the initiation ATG codon is followed by a signal
peptide of 20 amino acids. The position of the predicted signal
peptide cleavage site (Ala 21) of the human g2 chain is conserved.
The horse g2 polypeptide shows a domain organization identical to
that of the human and mouse g2 chains with 67 cysteine residues
and six putative N-glycosylation sites (Asn-X-Ser/Thr) that are all
conserved in the three species (Fig 3). The deduced primary
sequence of the horse g2 chain revealed > 90% identity at the
amino acid level of domains V, IV, III in horse and man, and >
80% identity in horse and mouse. Identity of domains I/II is 81.3%
in horse and man, and 76.6% in horse and mouse (Table II).
Identi®cation of mutation 1368insC in the horse laminin g2
chain To identify possible genetic mutations in the Lamc2 alleles
of the affected foals, total RNA was puri®ed from frozen skin
samples and used for RT-PCR ampli®cation. The coding sequence
of the g2 mRNA was reverse transcribed and PCR-ampli®ed using
the primer pairs listed in Table II. In the affected foal the 756 bp
cDNA fragment (nucleotides 1003±1759) obtained using primers
4L and 4R was found to contain a homozygous one base-pair
insertion at position 1368 (Fig 4A). This mutation, designated
Figure 3. Direct comparison of the primary structure of the horse, human, and mouse laminin g2 chain. The amino acid sequence of the
g2 polypeptides was aligned using the Clustal W alignment software (Thompson et al, 1994). Identity of the horse (upper line) g2 chain with the human
(middle line) and mouse (lower line) g2 polypeptides is 87.1% and 82.4%, respectively. Conserved amino acids are framed in black, semiconserved amino
acids are boxed in gray, and the nonconserved amino acids are indicated by light boxes. The gaps in the aligned sequences are ®lled in with a hyphen.
The GenBank accession numbers for the human and the mouse g2 chain are Z15008and NM_008485, respectively.
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1368insC, causes a shift in the open reading frame of the g2
messenger RNA and results in a downstream premature
termination codon (TGA) at residue 476 within the N-terminal
portion of domain III, 41 residues downstream of the proteolytic
cleavage site.
Direct nucleotide sequencing of genomic DNA puri®ed from
peripheral blood and ampli®ed by PCR using primers (L) 5¢-TG-
TTACTCAGGGGATGAGAA-3¢ and (R) 5¢-CTGGGGGCAG-
TTATTGCAC-3¢, which corresponds to the sequence within
exon 10 of the human LAMC2 gene, con®rmed the presence of
the homozygous mutation 1368insC in the affected foals. When the
phenotypically healthy dam and sire of the affected foals were tested
for the presence of this mutation, they were all found to be
heterozygous carriers (Fig 4A). To assess the frequency of this
mutation in the Belgian horse, samples for genomic DNA
extraction were obtained from Belgian horses at various breeding
farms in Canada and the U.S.A. Results in over 150 horses
con®rmed the Mendelian autosomal recessive transmission and that
over 48% of the animals screened were healthy carriers of the
mutation 1368insC (Fig 4B).
DISCUSSION
The ability to manipulate individual genes in the mouse provides a
potent means to unravel the molecular basis of human diseases and
explore new therapeutic strategies. Combining the power of this
technology with the study of inherited disorders in domestic
animals offers the possibility of devising animal models that
properly mimic rare human inherited conditions.
In this study we disclose the molecular defect of a mechan-
obullous disorder in North American Belgian horses that was
reported to exhibit the clinical, ultrastructural, and the recessive
mode of inheritance of JEB in humans (Gourreau et al, 1990).
Consistent with the etiology of JEB in man, blistering of the skin
and mucous epithelia of the affected foals occurs shortly after birth.
The course is severe in the oral and tongue epithelia, whereas the
distribution of the multifocal, irregular, hairless erosions and
ulcerations appear mainly restricted to the pressure points on the
limbs. Despite the limited extent of these blistered areas, the
animals are euthanized shortly after diagnosis is made because of the
devastating consequences of exungulation and the involvement of
the oral mucosa that makes nursing dif®cult. The long-term
evolution of skin blistering is not known, but the absence of
immunoreactivity to the antibodies against the laminin g2 chain
implies lack of expression of laminin 5 and severe JEB (Aberdam et
al, 1994b). In man and newborn laminin-5-null mice, absence of
laminin 5 compromises adhesion of the basal keratinocytes and
causes detachment of wide areas of the integument. In the
analogous situation, the affected foals display an involvement of the
skin predominantly involving the lower limbs. A similar reduced
tendency to blister compared to human patients was noted in the
case of the skin of sheep suffering from dystrophic EB, and also in
DEB (dystrophic epidermolysis bullosa) dogs and DEB knockout
mice after growth of the hair (Bruckner-Tuderman et al, 1991;
Heinonen et al, 1999; Palazzi et al, 2000). As in the JEB horses,
attenuation of the clinical phenotype in the animal skin is likely to
be due to the protection that dense hair provides against trauma and
the enhanced cohesion that hair follicles impart to the skin
compartments.
Absence of laminin 5 in the JEB foals could not be directly
demonstrated by immunohistochemistry because mAb GB3, which
recognizes native laminin 5 in man, does not crossreact with
laminin 5 in other mammals. The lack of reactivity of mAb GB3,
which is thought to bind an epitope of the human laminin g2 chain
(Matsui et al, 1995), contrasts with the considerable conservation
between the human and horse amino acid sequences of the g2
chain, as well as the matching domain organization of the two
polypeptides. The sequence identity is particularly high (> 90%) in
Table II.Sequence identity (percentage) between the
domains of the horse laminin g2 chain and the human and
mouse counterparts
Protein domains
I/II III IV V
Human g2 81.3 93 94 92.3
Mouse g2 76.6 90.7 88.8 86.4
Figure 4. Identi®cation of genetic mutation
1368insC. (A)Genomic DNA was isolated from
peripheral blood and the DNA fragment
harbouring mutation 1368insC was PCR
ampli®ed. The PCR ampli®cation products were
submitted to direct nucleotide sequencing. The
homozygous basepair insertion detected in the
JEB foal (a) results in a shift of the open reading
frame that generates a 58 bp downstream
premature termination codon (TGA). Genotyping
of the dam (b) and the sire (not shown) disclosed
heterozygosity for mutation 1368insC. A wild-
type horse genomic DNA was used as a control
(c). (B) Mendelian inheritance of mutation
1368insC was assessed by genotyping in an inbred
Belgian horse population. Affected foals are
indicated by black-®lled and numbered symbols,
unaffected individuals are indicated by un®lled
symbols, and carriers by half-®lled symbols.
Generations are indicated by roman numerals on
the left.
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the N-terminal domains which constitute the short arm of the g2
chain. In addition to overall conservation, the cysteine residues
involved in the disul®de bridges giving rise to the laminin-type
EGF-like modules are all preserved, as well as the putative N-
glycosylation sites and the proteolytic site recognized by BMP-1
(Amano et al, 2000), suggesting a functional relevance to these
protein segments. Indeed, whereas the C-terminal domain of
laminin 5 interacts with the integrin cellular receptors, the N-
terminal structures of the b3 and g2 chains are thought to provide
the binding sites for interactions with the extracellular matrix
(Champliaud et al, 1996; Rousselle et al, 1997). In this respect, the
horse g2 chain conserves both the cluster of four arginines (R 74±
80) and the peptidic sequence thought to de®ne the heparin
binding site and the ®bulin-2 binding consensus sequence identi-
®ed in the mouse and man, respectively (Sasaki et al, 2001). The 5¢
noncoding nucleotide sequence upstream of the putative translation
codon ATG appears also to be highly conserved in comparison to
the corresponding human sequence. In particular, analysis of
approximately 0.2 kb of the putative promoter region identi®ed
the consensus sequence for the GATAA motif and two AP-1
consensus binding sites previously detected in the human sequence
(Salo et al, 1999), indicating a strict interspecies conservation of the
regulatory mechanisms that govern the expression of the g2 chain.
Conversely, in the C-terminal portion of the g2 chain, which
interacts with the laminin a3 and b3 chains, the number of amino
acid substitutions is higher compared to man and mouse, 81.3% and
76.6% identity, respectively, indicating that the phylogenic evolu-
tion of the primary sequence of this portion of the molecule does
not compromise the functionality of laminin 5.
The identi®cation of the homozygous mutation 1368insC in the
Lamc2 gene of the affected foals con®rms the diagnosis of JEB. This
mutation causes a shift in the open reading frame and generates a
premature termination codon within domain III of the laminin g2.
This predicts expression of a truncated N-terminal g2 polypeptide
missing the a-helical C-terminal domain I/II, which contributes to
the assembly of laminin 5. Synthesis of the truncated g2 polypeptide
is unlikely, however, because the epithelia of the affected foals do
not react with pAb SE1097 (Gagnoux-Palacios et al, 2001), which
is speci®c to the N-terminal g2 chain domains and immunoreactive
in wild-type horses (not shown). Rapid decay of the mutated g2
mRNA transcript caused by the presence of the premature
termination codon is a possible explanation for this observation
(Cooper, 1993; Cui et al, 1995).
Sporadic cases of JEB have been reported in Belgian, Comtois,
Breton, and other draft horse breeds in Europe (Butz and Meyer,
1957; Gourreau et al, 1990). Occurrence of JEB in speci®c breeds
of draft horses in different countries is associated with a narrow
range of phenotypic variation in the stocks and results from the
designed crossing of closely related breeds. The condition in these
other draft horse breeds may therefore be linked to the genetic
mutation 1368insC. The relatively large percentage of hetero-
zygous carriers of the genetic mutation 1368insC in the North
American Belgian horse at present is likely to have resulted from a
genetic bottlenecking phenomenon that occurred in the early
1950s when there was a marked drop in the number of Belgian
horses. This population rapidly increased in the 1970s with
subsequent breeding of consanguineous individuals. This situation
is akin to that of geographically isolated human communities settled
in remote regions where combination of limited founder pool,
genetic drift, and migrations of healthy carriers favors spreading of a
unique mutation event in several areas. This is the case, for
instance, for mutation R635X in the b3 chain of laminin 5, which
is carried in a heterozygous state by a relatively high percentage
(2%) of the northern Scandinavian population (Gedde-Dahl and
Anton-Lamprecht, 1996). At present, this ancient sequence
variation accounts for 45% of JEB cases in Europe and the
U.S.A., whereas it is absent in Japanese and Arabian gene pools
(Shimizu et al, 1997).
Laminin 5 is widely distributed in the basement membrane of
epithelial tissues (Aberdam et al, 1994a) and its expression has been
associated with the branching morphogenesis of mammary
epithelial cells (Stahl et al, 1997). Speci®cally, the role of laminin
5 has been considered crucial in the differentiation of the ureteric
bud, which is required for normal kidney development (Zent et al,
2001), and in the formation of the submandibular gland ducts
(Kadoya and Yamashina, 1999). Similar to laminin-5-null Herlitz
JEB patients, however, the affected foals are normally developed at
birth, with the exception of teeth that present enamel hypoplasia
and abnormal shape. In particular, in the newborn JEB horses the
teeth are apparent and not protected by the gingiva as in the wild-
type animals. These observations con®rm the relevance of laminin
5 in odontogenesis, and strengthen the idea that laminin 5
contributes to the tooth morphogenesis by mediating adhesion of
ameloblasts to the enamel matrix and attachment of the marginal
gingiva to the tooth surface (Hormia et al, 1998; Sahlberg et al,
1998).
In conclusion, in this study we show that (i) the horse JEB
genetically corresponds to the severe Herlitz form of JEB in man;
(ii) the amino acid sequence and structure of the horse laminin g2
chain are virtually identical to the human counterpart; (iii) the
moderate eruption of skin blisters in the affected animals with
respect to the human Herlitz JEB patients correlates with the
protection provided by hair.
In view of ex vivo therapeutic approaches of JEB cells, our
observations suggest that the affected foals are a convenient source
of epithelial cells from tissues involved in the disease, such as
mucosa of the oral cavity and alimentary tract, cornea, and
conjunctiva, that cannot be obtained from human JEB patients. On
the other hand, our results imply that only hairless strains of mice
with recessive skin disorders generated by inducible knockout of
speci®c epidermal genes (Wojcik et al, 2001) would be suitable
models for an in vivo gene therapy approach to skin blistering
diseases.
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